Stockscreener 앱 받기
32.45
2.61%
-0.87
전일 마감가:
$33.32
열려 있는:
$32.48
하루 거래량:
636.87K
Relative Volume:
0.51
시가총액:
$3.25B
수익:
$47.30M
순이익/손실:
$-225.97M
주가수익비율:
-13.81
EPS:
-2.35
순현금흐름:
$-188.86M
1주 성능:
-5.20%
1개월 성능:
+3.34%
6개월 성능:
-22.70%
1년 성능:
+244.11%
1일 변동 폭
$32.03
$33.47
1주일 범위
$32.03
$34.91
52주 변동 폭
$6.76
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
명칭
Scholar Rock Holding Corp
전화
857-259-3860
주소
301 BINNEY STREET, CAMBRIDGE, MA
SRRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
32.45 | 3.25B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-26 | 재확인 | H.C. Wainwright | Buy |
| 2024-10-07 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-28 | 개시 | Raymond James | Strong Buy |
| 2023-10-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-04-03 | 재개 | Piper Sandler | Overweight |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2022-07-12 | 개시 | Truist | Buy |
| 2022-03-23 | 개시 | H.C. Wainwright | Buy |
| 2021-12-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-06 | 개시 | JP Morgan | Overweight |
| 2020-03-12 | 개시 | Robert W. Baird | Outperform |
모두보기
Scholar Rock Holding Corp 주식(SRRK)의 최신 뉴스
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule - marketscreener.com
Scholar Rock Expands Team With 11 New Hires, Awards $10.5M in Stock Options for SMA Drug Development - Stock Titan
Scholar Rock at Goldman Sachs Conference: Strategic Focus on SMA By Investing.com - Investing.com Nigeria
Transcript : Scholar Rock Holding Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 09 - marketscreener.com
Scholar Rock Holding Co. (NASDAQ:SRRK) Stake Increased by California State Teachers Retirement System - MarketBeat
Scholar Rock (NASDAQ:SRRK) Trading Up 5.9%Here's What Happened - MarketBeat
Lifesci Capital Weighs in on Scholar Rock Q2 Earnings - MarketBeat
Scholar Rock (NASDAQ:SRRK) Upgraded at Lifesci Capital - MarketBeat
Exploring Three High Growth Tech Stocks In The US Market - Yahoo Finance
Mackenzie Financial Corp Invests $212,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Analysts Set Expectations for Scholar Rock Q2 Earnings - Defense World
Scholar Rock Spotlights Revolutionary SMA Treatment at Goldman Sachs Healthcare Conference 2025 - Stock Titan
Squarepoint Ops LLC Takes $873,000 Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) Stock Rating Upgraded by Lifesci Capital - Defense World
Scholar Rock at Jefferies: Leadership Changes and Drug Launch Plans By Investing.com - Investing.com South Africa
Scholar Rock at Jefferies: Leadership Changes and Drug Launch Plans - Investing.com
Ameriprise Financial Inc. Has $813,000 Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Insider Selling: Scholar Rock Holding Co. (NASDAQ:SRRK) Director Sells 5,400 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) Trading Down 6.2%Time to Sell? - MarketBeat
Scholar Rock appoints new Chief Brand Officer By Investing.com - Investing.com South Africa
Wellington Management Group LLP Buys 1,525,845 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Director Jeffrey S. Flier Sells 6,075 Shares - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Insider Akshay Vaishnaw Sells 6,750 Shares - MarketBeat
Regeneron's weight-loss drug helps patients on Wegovy preserve muscle - marketscreener.com
Scholar Rock appoints new Chief Brand Officer - Investing.com Australia
Scholar Rock (SRRK) Appoints Rebecca McLeod as Chief Brand Officer | SRRK Stock News - GuruFocus
Scholar Rock Taps Blockbuster VYVGART Launch Executive to Lead Crucial SMA Drug Commercialization - Stock Titan
Polar Asset Management Partners Inc. Sells 28,000 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Millennium Management LLC Trims Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Director Michael Gilman Sells 3,375 Shares - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Average Rating of "Buy" by Brokerages - MarketBeat
Nuveen Asset Management LLC Has $13.16 Million Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Voloridge Investment Management LLC Has $8.71 Million Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Multiple Executives Sell Shares at Scholar Rock Holding Corp - TradingView
Bank of America Corp DE Sells 365,028 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Stake Decreased by Two Sigma Advisers LP - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Acquired by ProShare Advisors LLC - MarketBeat
Two Sigma Investments LP Has $17.18 Million Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock CEO Reveals Latest Spinal Muscular Atrophy Treatment Updates at Major Healthcare Conference - Stock Titan
Scholar Rock to Present at the Jefferies Global Healthcare Conference - Yahoo Finance
Millennium Management LLC Sells 524,642 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Corp (SRRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.91%
1.17%
자본화:
|
볼륨(24시간):